These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6228853)

  • 1. [Chronic obstructive bronchopneumopathies. Effect of nifedipine during the exercise test].
    Feret J; Bruet A; Simon N; Duruy D; Nouailhat F
    Presse Med; 1983 Dec; 12(44):2819-20. PubMed ID: 6228853
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Arnaud A
    Cardiology; 1987; 74(3):196-204. PubMed ID: 3594508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects of the administration of nifedipine over an 18-month period in pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
    Vestri R; Joet FP; Saadjian A; Arnaud A
    Presse Med; 1988 Feb; 17(5):213-4. PubMed ID: 2965386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulsed Doppler echocardiography assessment of acute hemodynamic effects of nifedipine on pulmonary hypertension in chronic obstructive lung disease].
    Yuan H
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr; 14(2):96-7, 127-8. PubMed ID: 1879026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of nifedipine in patients with unstable chronic obstructive pulmonary disease].
    Seoane M; Verdejo J; Sandoval J; Lupi E
    Arch Inst Cardiol Mex; 1986; 56(2):109-16. PubMed ID: 2942120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Muramoto A; Caldwell J; Albert RK; Lakshminarayan S; Butler J
    Am Rev Respir Dis; 1985 Nov; 132(5):963-6. PubMed ID: 4062050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of posture, hydralazine, and nifedipine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease.
    Corriveau ML; Rosen BJ; Keller CA; Chun DS; Dolan GF
    Am Rev Respir Dis; 1988 Dec; 138(6):1494-8. PubMed ID: 3144218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].
    Saadjian A; Philip-Joet F; Vestri R; Arnaud A
    Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):197-202. PubMed ID: 2735734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases by trapidil (Rocornal) in an acute trial].
    Schauer J; Orschekowski H; Winkler J; Steiniger L
    Z Erkr Atmungsorgane; 1991; 177(3):204-16. PubMed ID: 1808871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hemodynamic data in chronic bronchopneumopathies. Pharmacodynamic studies].
    Marcatili S; Caputi M; Caruso M; Maselli R
    Bronchopneumologie; 1977; 27(3):184-8. PubMed ID: 890506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs].
    Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB
    Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term clinical study of nifedipine in the treatment of pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
    Vestri R; Philip-Joft F; Saadjian A; Lagier F; Arnaud A
    Presse Med; 1987 Sep; 16(29):1437. PubMed ID: 2958810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of nifedipine and pulmonary hypertension in a group of COPD decompensated patients.
    Raimondi GA; Raimondi AC; Dzienisik RS; Borrajo MC; González SB
    Medicina (B Aires); 1986; 46(3):311-9. PubMed ID: 3574090
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
    Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
    Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension in chronic obstructive bronchitis].
    Macaluso S; Pesce L; Saccarola L; Cannizzaro G; Del Torre L
    Arch Monaldi Mal Torace; 1988; 43(4):305-15. PubMed ID: 3272552
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC; Joshi RC; Mehta R; Cunnington AR
    Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced pulmonary hypertension: nifedipine only temporarily reduces pulmonary artery pressure and vascular tone.
    Agostoni P; Doria E; Fiorentini C; Galli C; Tamborini G; Guazzi M
    Ann Ital Med Int; 1989; 4(3):181-3. PubMed ID: 2702029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
    Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
    Weitzenblum E; Oswald M; Apprill M; Ehrhart M
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1506-10. PubMed ID: 2692144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.